MYCOBACTERIUM TUBERCULOSIS : AGENT POTENTIEL DE BIOTERRORISME



Similar documents
19th Swiss TB Symposium Münchenwiler,

Laboratory Techniques for the Diagnosis of TB what s available? Dr. Annette Jepson

Performance Evaluation and Clinical Application of MTB NAAT in Orange County, CA. Minoo Ghajar Orange County Public Health Laboratory

Innovations in Molecular Epidemiology

CAN CORD FORMATION IN BACTEC MGIT 960 MEDIUM BE USED AS A PRESUMPTIVE METHOD FOR IDENTIFICATION OF M. TUBERCULOSIS COMPLEX?

Appendix B: Provincial Case Definitions for Reportable Diseases

Tuberculosis and HIV/AIDS Co-Infection: Epidemiology and Public Health Challenges

IMA Knowledge June, 2015

TB Prevention, Diagnosis and Treatment. Accelerating advocacy on TB/HIV 15th July, Vienna

Clinical description 2 Laboratory test for diagnosis 3. Incubation period 4 Mode of transmission 4 Period of communicability 4

Mycobacteria Testing Systems

DIRECTLY OBSERVED TREATMENT SHORT-COURSE (DOTS)

IDENTIFICATION OF M. tuberculosis

Maria Dalbey RN. BSN, MA, MBA March 17 th, 2015

Jessica Minion, MD PGY-5 Medical Microbiology MSc Epidemiology McGill University, Montreal, QC

AURAMINE O STAIN. Preanalytical Considerations

Perils and Pitfalls in Clinical Trials of Diagnostic Tests for Tuberculosis. Richard O Brien, MD Foundation for Innovative New Diagnostics Geneva

Metagenomics revisits the one pathogen/one disease postulates and translate the One Health concept into action

JIANGSU CARTMAY INDUSTRIAL CO.,LTD mail:

Paediatrica Indonesiana. Limitations of the Indonesian Pediatric Tuberculosis Scoring System in the context of child contact investigation

ATYPICAL MYCOBACTERIA

TUBERCULOSIS SCREENING AND TREATMENT IN PREGNANCY. Stephanie N. Lin MD 2/12/2016

Table. Positive Purified Protein Derivative Results (Pediatrics In Review Apr 2008)

The genetic diversity of Mycobacterium avium subsp. hominissuis

VersaTREK Myco Bottles, VersaTREK Myco GS, VersaTREK Myco AS, VersaTREK Myco PVNA, VersaTREK Connector,

GROWTH OF ACANTHAMOEBA CASTELLANI WITH THE

SUPPLEMENTARY FIGURES

Transmission & Pathogenesis of Tuberculosis

Standard Operating Procedure (SOP)

Bacterial Transformation with Green Fluorescent Protein. Table of Contents Fall 2012

Haley Blake, BA Senior Disease Investigation and Intervention Specialist Southern Nevada Health District

Biosafety in the Mycobacteriology Laboratory

CONTENT. Chapter 1 Review of Literature. List of figures. List of tables

QuantiFERON TB Gold In Tube Method (QGIT Test) Manufacturer: Cellestis Inc. (USA) a QIAGEN Company

Chapter 1 Overview of Tuberculosis Epidemiology in the United States

09/27/2006 Centers for Disease Control and Prevention Division of Tuberculosis Elimination

Management of Tuberculosis: Indian Guidelines

IMPLEMENTING TUBERCULOSIS DIAGNOSTICS Policy framework

Raw Milk Quality Tests Do They Predict Fluid Milk Shelf-life or Is it time for new tests?

Differentiation of Mycobacterium bovis Isolates from Animals by DNA Typing

Sur les traces du Campylobacter au Luxembourg

Identification of the VTEC serogroups mainly associated with human infections by conventional PCR amplification of O-associated genes

Thermo Scientific VersaTREK. Automated Microbial Detection System. Value through versatility, flexibility and. excellence in recovery

X-Plain Pediatric Tuberculosis Reference Summary

EVALUATION OF DARK FIELD MICROSCOPY, ISOLATION AND MICROSCOPIC AGGLUTINATION TEST FOR THE DIAGNOSIS OF CANINE LEPTOSPIROSIS


Immunomodulatory Effects of Mycobacteria. Toh S.S. 1 and Seah G.T. 2

Medical Microbiology Microscopic slides and media

U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Public Health Service Centers for Disease Control and Prevention

What is an IGRA? What is an IGRA? Are they available here? How do I use them? Learning Objectives

How To Test For Drug Resistance In Mycobacterium Tuberculosis

Tuberculousmeningitis: what is the best treatment regimen?

Chapter 20: Antimicrobial Drugs

Tuberculosis OUR MISSION THE OPPORTUNITY

BD Affirm VPIII. Microbial Identification System

Chikungunya: An emerging outbreak from East Africa to Indian Ocean,

Acknowledgements. Developing collaborative lab experiments across disciplines through the identification of bacteria

IIID 14. Biotechnology in Fish Disease Diagnostics: Application of the Polymerase Chain Reaction (PCR)

CHECKLIST OF KEY ACTIONS FOR THE USE OF LIQUID MEDIA FOR CULTURE AND DRUG SUSCEPTIBILITY TESTING (DST)

Childhood Tuberculosis Some Basic Issues. Jeffrey R. Starke, M.D. Baylor College of Medicine

About Our Products. Blood Products. Purified Infectious/Inactivated Agents. Native & Recombinant Viral Proteins. DNA Controls and Primers for PCR

TB CARE EARLY DETECTION AND PREVENTION OF TUBERCULOSIS (TB) IN CHILDREN. Risk factors in children acquiring TB:

Tuberculosis in Children and Adolescents

Medical Microbiology Culture Media :

Testing Waste Water for Fecal Coliforms and/or E.coli using Colilert and Colilert -18 & Quanti-Tray

MODULE THREE TB Treatment. Treatment Action Group TB/HIV Advocacy Toolkit

INTRODUCTION TO BACTERIA

Visualization of tuberculosis patient and Mycobacterium tuberculosis complex genotype data via host-pathogen maps

Disc Diffusion Susceptibility Methods

Core Curriculum on Tuberculosis: What the Clinician Should Know Sixth Edition 2013

Biological Sciences Initiative

Annex to the Accreditation Certificate D-PL according to DIN EN ISO/IEC 17025:2005

Guideline. Treatment of tuberculosis in pregnant women and newborn infants. Version 3.0

MANAGEMENT OF TUBERCULOSIS IN PRISONS: Guidance for prison healthcare teams

An Evaluation of QuantiFERON-TB Gold In-Tube and Immunological Tests for TB Diagnosis in Iraqi Patients

Transcription:

MYCOBACTERIUM TUBERCULOSIS : AGENT POTENTIEL DE BIOTERRORISME Michel DRANCOURT, MD, Ph.D. Unité des Rickettsies URMITE UMR CNRS 7872 Faculté de Médecine Aix-Marseille Université

http://www.mediterranee-infection.com/

Pulmonary tuberculosis

Ecrouelles : tuberculose ganglionnaire

EPIDEMIOLOGY Tuberculosis = major public health problem 8 millions of new cases and 2 millions of deaths by year Etiologic agent = Mycobacterium tuberculosis

Mycobacterium tuberculosis : diagnostic microbiologique Prélèvements Examen direct : coloration de Ziehl Isolement et culture Détection moléculaire Antibiogramme

Direct microscopy : presence of acid-fast bacilli

M. tuberculosis : cords

M. tuberculosis : Isolement et culture Prélèvements : classe 2 Souches : classe 3

Pathogènes de Groupe C Pathogènes émergents : Disponibles Faciles à cultiver Faciles à disséminer Induisent une forte mortalité

M. tuberculosis Belongs to Actinobacteria high GC% gram positive bacteria) M. tuberculosis complex of 6 species Two complete genome sequences available Acid fast bacilli Grown on cultured cells M. komossense M. farcinogenes M. sphagni M. aichiense. M. gilvum M. diernhoferi M. gadium M. obuense M. chubuense M. avium M. leprae M. paratuberculosis M. africanum M. microti M. tuberculosis M. bovis 0.005

Isolation and culture Manual: Solid media Automatic: Liquid media

omparative performance of different isolation systems for the culture of M. tuberculosis rom respiratory specimens Study Samples tested (Number) Culture media used Time to detection in days (range) References Smear positive Smear negative 1 Respiratory tract (2832) - Bactec MGIT 960 - Middlebrook 7H11 - Lowenstein-Jensen - Colstsos medium 11 (3-39) 10.4 (3-35) 21.4 (6-60) 21.3 (6-60) 16.1 (16-34) 20.7 (10-47) 26.7 (14-66) 26.8 (11-60) Idigoras et al.(2000), Eur J Clin Microbiol Infect Dis 2 Respiratory tract (462) - BacT/Alert MB - Bactec 460 - Lowenstein-Jensen 15.3 (7-30) 11.5 (4-35) 19.1 (14-28) Harris et al. (2000), J Clin Pathol 3 Respiratory tract (915) - BacT/Alert 3D - Lowenstein-Jensen 14.3 (6-24) 19.4 (13-30) 17.4 (7-35) 24.6 (16-35) Carricajo et al.(2001), JCM 4 Respiratory tract (1396) - Bactec MGIT 960 - Middlebrook 7H11 - Lowenstein-Jensen 9.1 16.1 17.6 16.2 25.2 23.5 Lee et al. (2003), Int J Tuberc Lung Dis 5 Respiratory tract (7153) - Bactec 460 - Lowenstein-Jensen 13.3 31.2 Rodrigues et al.(2007), Ind J Med Microbiol 6 Respiratory tract (2566) - Bactec MGIT 960 - Lowenstein-Jensen 9 (7-12) 26 (21-33) 14 (12-17) 35 (29-42) Srisuwanvilai et al. (2008), Diagn Microbiol Infect Dis 7 Respiratory tract (147) 8 Respiratory tract (79) 9 Respiratory tract (1916) 10 Respiratory tract (319) - Bactec MGIT 960 - Lowenstein-Jensen 10.3 (2-34) 26.1 (14-56) Otu et al.(2008), J Infect Developing Countries - Bactec MGIT 960 16.6 (11-38) Aono et al.(2009), Diagn Microbiol Infect Dis - Bactec MGIT 960 - Lowenstein-Jensen - BacT/Alert 3D - Lowenstein-Jensen - Gottsacker medium 9.5 21 14 34 14 (6-48) 19 (10-60) 19 (10-60) Muyoyeta et al.(2009), Int J Tuberc Lung Dis Tessema et al.(2011), JCM

Le temps de croissance est le premier élément de classification des mycobactéries Croissance rapide < 7 jours : - M. chelonae-abscessus group - M. fortuitum group - M. mucogenicum group - M. mageritense group - M. porcinum group - M. smegmatis group - M. septicum group - M. moriokaense group Croissance lente > 7 jours : - M. tuberculosis - M. marinum / ulcerans - M. leprae - M. xenopi - M. avium - intracellulare - M. haemophilum

Isolement et culture de Mycobacterium tuberculosis sur gélose au sang M. tuberculosis cultive sur milieux à l œuf Mise en évidence fortuite de la croissance sur gélose au sang Etude systématique de la croissance sur gélose au sang

Etude de croissance de M. tuberculosis sur gélose au sang 38 souches calibrées à 10 6 mycobactéries/ml Inoculées en parallèle sur GS / LJ Culture significativement plus riche sur GS à 6 jours (p < 0,001, test ANOVA)

Etude de croissance de M. tuberculosis sur gélose au sang 15 prélèvements respiratoires et 8 prélèvements ganglionnaires Inoculation en parallèle GS / LJ Isolement apparemment plus rapide sur GS mais p = 0,11 (test ANOVA)

2 Optimization of culture media and detection tools : optimal detection tools - GFP3 filter -Zoom = 0,8-1,6 - Maximum magnification (230x) -wavelength = 460-540 nm -Camera LeicaDC300F Micro-colony: 0.335 mm (Joshiet al., 2012, Patiño et al, 2008) 2 mm

Optimization of culture media and detection tools : optimal condition 2 Temperature effect Atmosphere * * * * ph effect in 7-day culture Time to detection in Days Times to detection (Days) 7 6 5 4 3 2 70 1 * 60 0 50 1 Anaerobic 5% CO2, 2.5 % O2 Micoraerophilic Atmosphere 40 M.tuberculosis M.bovis DSMZ 30 nbr of colony 5% CO2 Ambient atmosphere M.bovis BCG Pasteur 20 10 5 6 7 8 9 ph 6.5 0

2 Optimization of culture media : solid medium 55 M. tuberculosis clinical isolates tested in solid media days * Subculturing for clinical isolates including reference strain M. tuberculosis H37Rv was 3±0.days in MOD4 vs 4.5±1.2 days in Middelbrook 7H10 (p=0.023) MOD4 7H10 * P<0.05 40 sputum specimens including 16 specimens exhibiting acid-fast bacilli on microscopy observation. days culturing of clinical specimens was 6.3±2.4 days in MOD4 vs 8.5±2.8 days in Middelbrook 7H10 (p=0.0031) 26 % time saving. MOD4 7H10 P<0.05

Colonies de Mycobacterium tuberculosis sur gélose au sang

Isolement et culture sur cellules Entre Mai 1998 et Août 2004 70 prélèvements positifs: 48 prélèvements ganglionnaires 7 prélèvements d abcès 2 liquides péricardiques 7 liquides céphalo-rachidiens 2 liquides articulaires 1 biopsie ostéomédullaire 3 biopsies cutanées

Isolement et culture sur cellules Parmi les 70 prélèvements positifs: 53 M. tuberculosis 11 M. avium - intracellulare 1 BCG 1 M. xenopi 3 M. abcessus / M. gordonae 1 M. fuerthensis

Rapid identification: GenExpert Identification of M. tuberculosis isolmates Detection of M. tuberculosis in sputum Detection of rifampicin - resistance

MALDI-TOF identification (a) 70% ethanol inactivation (b) without Tween-20 (c) ß-mercaptoethanol (d) acetone (e) absolute ethanol (f) 0.1 M NaOH (g) 10 % TFA (h) 0.1 M HCl (i) final protocol

Mycobacterium tuberculosis complex Source Infections humaines M. tuberculosis Homme +++ M. canettii Homme ++ M. bovis BCG Vaccin ++ M. bovis Bovins + M. microti Rongeurs + M. caprae Caprins - M. pinnipedii Phoques -

M. tuberculosis complex : génomes publiés M. tuberculosis CDC 1551 NC 002755 M. tuberculosis H37 RV NC 000962 M. tuberculosis F11 NC 009565 M. tuberculosis H37 Ra NC 009525 M. bovis AF 212297 NC 002945 M. bovis BCG Pasteur NC 008769

Molecular Identification 1-16S rrna 94% Mycobacteria genus 96% Pathogenic RGM 2- rpob -Ringet et al. 1998 -Kim et al. 1999

Molecular Identification 1-16S rrna (gold standard) 94-100% 2- rpob (alternative tool) 2.1. Identification of mycobactial species by comparative sequence analysis of the RNA polymerase (rpob). Kim et al. 1999 2.2. rpob-based identification of nonpigmentated and latepigmenting rapidly growing mycobacteria. Adekambi et al. 2003

Strictly human disease Tuberculosis Transmission through air Reactivation (Immunodepression) Prevalence unchanged Families regroupement Student group Hospital / Laboratory Homeless and prison Promiscuity Immunocompromized

M. tuberculosis genotyping : current methods Profile Analysis Restriction profile Fragment Amplification profile Fragment BET staining Probe staining BET staining Probe staining PFGE RFLP-IS6110 VNTR MIRU Spoligotyping

MST approach Spacer A Spacer B Spacer C Orf 1 Orf 2 Orf 3 Orf 4 Seq 1 Seq 2 Seq 3 Seq 1 Seq 2 Seq 3 Seq 1 Seq 2 Seq 3 Strain Spacer A Spacer B Spacer C MST type Strain 1 SeqA1 SeqB1 SeqC1 MST 1 type Strain 2 SeqA2 SeqB2 SeqC2 MST 2 type Strain 3 SeqA3 SeqB3 SeqC3 MST 3 type SeqA1 differs from SeqA2 by : - Mutation - Deletion / Insertion These 2 events have the same weight Strain 4 SeqA1 SeqB1 SeqC1 MST 1 type

Materials and Methods Choice of spacers Genome H37Rv GenBank accession number AE 000516 Genome CDC1551 GenBank accession number AL 123456 Data Difseq Software Data of differences between the two genomes Filtre Data of differences located on the spacer of H37Rv/CDC1551 Alignment Dotplot

Phylogenic analysis MST and VNTR ST1 Black Africa (9) ST17 Tunisia (1) ST23 Tunisia (1) ST3 Algeria (1) ST11 Algeria (5) ST8 Algeria (2) ST4 Algeria (14) ST16 Algeria (1) ST12 Thailland (2) ST20 Philippines (1) ST7 Thailland (1) ST2 Vietnam (1) ST14 Vietnam (3) ST26 Kurdistan (1) ST6 Poland (1) ST9 Poland (1) ST5 Italia, France (3) ST15 Spain (2) ST10 France (3) ST19 France (2) ST25 France (1) ST22 France (1) ST13 Algeria (1) ST24 France (1) ST18 France (1) ST21 Turkey (1) VNTR 1 VNTR 4 VNTR 2 VNTR 3

Genomic regions associated with decreased susceptibility to antituberculosis agents Antituberculosis agent Gene Product Mutation frequency among Drug-resistant clinical isolates (%) Streptomycin rpsl Ribosomal protein S12 ~ 60 rrs 16SrRNA < 10 Rifampin rpob β subunit of RNA polymerasme > 95 Isoniazid katg Catalase-peroxidase 60-70 oxyr-ahpc Alkylhydroreductase ~ 20 inha Enoyl ACP reductase < 10 kasa β-ketoacyl-acp synthase < 10 ndh NADH dehydrogenase NA Ethambutol embcab Arabinosyltransferases ~ 70 Pyrazinamide pnca Amidase 70-100 Ethionamide inha Enoyl ACP reductase < 10 etha Flavoprotein monooxygenase NA Kanamycin rrs 16SrRNA ~ 65 Fluoroquinolone gyra DNA gyrase α subunit > 90 gyrb DNA gyrase β subunit NA Capreomycin tlya rrna methyltransferase NA rrs 16SrRNA NA Para-aminosalicylic acid thya Thymidylate synthase NA

Strictly human disease Tuberculosis Transmission through air Reactivation (Immunodepression) Prevalence unchanged Families regroupement Student group Hospital / Laboratory Homeless and prison Promiscuity Immunocompromized

M. tuberculosis in animals M. tuberculosis in captive mammals : Cattle, elephants, dogs, seals M. tuberculosis in wild mammals : mongooses (Mungos mungo), suricates (Suricata suricatta). M. tuberculosis in birds : canary (Serinus canaria forma domestica), amazons parrots. M. tuberculosis in non-human primates : old world monkeys like rhesus macaques (Macaca mulatta). Many non-human cases of infection with M. tuberculosis M. tuberculosis in amoeba : Acanthamoeba polyphaga M. tuberculosis persitance in biofilm and soil

Methodology 1 2 3 1 2 3 1 2 3 1 2 3 M.tb + soil M.tb + soil + 0.1% cellulose control soil control soil + 0.1% cellulose Monthly sampling of 250 mg soil + 250 ml PBS, serial dilution and plating on 7H10 agar Check colonies by Ziehl staining & identify each species by MALDI-TOF

1 M. tuberculosis Study of the survival of M. tuberculosis complex in soil (with Felix M Ba Medie) CFU (every month) M. bovis Sterilized soil M. canetti Long-term survival of tuberculosis mycobacteria in soil Ramzi Ghodbane, Felix Mba Medie, Bernard Henrissat and Michel Drancourt (in preparation) 13 months Infection in on BALB/c mice CFU Electronic microscopy WEIGHT (gr) Electronic microscopy Immuno-glod (in progress) Incubation in ambient temperature on NSB3 (18-25 C).

Preliminary results of MTC organisms in soil Negative controls (soil alone) Negative controls (soil + 0.1% cellulose) Mycobacterium bovis Mycobacterium canettii Mycobacterium tuberculosis

Preliminary results of MTC organisms in soil P = 0.31 P = 0.19 P = 0.03 Mba Medie, F. et al: Persistence of tuberculosis mycobacteria in soil In preparation

Mycobacteria-amoeba: Background Environmental mycobacteria & amoeba, Acanthamoeba polyphaga (2) Multiplication Trophozoite Trophozoites 7 days Excystment Encystment 1-3 days Cr Ed Ec Cyst composition Mature cysts Op 2 µm 2- Adékambi, T. et al., Applied & Environmental Microbiology. 2006; 72: 5974-5981 Os

Mycobacterium organisms escape from the amoebal trophozoite Carlson F. et al. Science 2009, vol 323, 1678

What is known about the interactions of MTC and amoeba Taylor J.S. et al., Applied & Environmental Microbiology. 2003; 69: 4316 4319 Hagedorn, M. et al., Science. 2009; 323: 1729 733

Microscopy analysis of infected A. polyphaga A B 2 µm M. tuberculosis in the trophozoite M. canettii in trophozoite 2 µm M. bovis in trophozoite 2 µm M. avium in trophozoite 2 µm MTC mycobacteria are indeed internalized

Microscopy analysis of infected A. polyphaga cysts 2 µm 2 µm M. tuberculosis in the cyst M. avium in the cyst D 2 µm M. tuberculosis in the cyst 2 µm M. tuberculosis in the cyst

Summary Bacteria size (nm) 3000 2500 2000 1500 1000 500 0 avium bovis M. tb * Ma Mb Mt Mc Ma Mb Mt Mc canettii Uptake Culture CFU/mL Ma 400 300 200 100 Bacteria uptake by A. polyphaga 0 M. avium M. bovis M. t b M. canet t ii Mb * Ma Mb Mt Mc Mt Mc EM Amoebal trophozoite Encystment Mt, Mb Ma CFU/mL 400 300 200 100 0 Intracystic bacteria * Ma Mt Mb M. avium M. tuberculosis M. bovis Culture Ma, Mt, Mb Excystment Visible bacillis o cyst Visible into cyst * 14 12 Amoebal Cysts 10 8 6 Ejectosome, [Hagedorn, M., et al. Science. 2009; 323: 1729-1733 ] 4 2 0 Ma Mt Mb M. avium M.bovis M. tb Out Mba Medie, F. et al: Mycobacterium tuberculosis complex mycobacteria EMas amoeba-resistant organisms. PloS ONE. 2011; 6: e20499

Structure of Acanthamoeba cyst

Ultrastructure and composition of Acanthamoeba polyphaga cyst wall

Cellulose: The target for GH and CBM In plants n up to 14000

Profil of cellulolytic bacteria Among mycobacteria, the combination of MtCel6, MtCel12, MtCBM2 is unique to MTC members 12

Organization of MtCel6, MtCel12 & MtCBM2 in mycobacteria M. tuberculosis H37Rv M. tuberculosis H37Ra M. bovis GH6 1142 bp GH6 1142 bp GH6 1143 bp GH6 1143 bp GH6 1142 bp 105bp 1.148 Mb CelA2a 1.015 Mb CelA2b 456bp 105bp 1.148 Mb CelA2a 1.023 Mb CelA2b 105bp 456bp 1.152 Mb CelA2a CelA2b 456bp M. tuberculosis F11 1.019 Mb M.tuberculosis CDC1551 M. bovis BCG Tokyo M. bovis BCG Pasteur GH6 1143 bp GH6 1142 bp 105bp 1.149 Mb CelA2a 1.012 Mb CelA2b 105bp 456bp 1.148 Mb CelA2a 1.015 Mb CelA2b 105bp 456bp 1.148 Mb CelA2a 1.015 Mb CelA2b 105bp 456bp 1.149 Mb CelA2a CelA2b 456bp Conclusion: Similar organization for all MTC organisms CBM2 428 bp CBM2 429 bp CBM2 429 bp CBM2 429 bp CBM2 428 bp CBM2 428 bp 26

Acanthamoeba polyphaga cysts, Congo red staining

Acanthamoeba polyphaga cysts, calcofluor staining

Summary 1,500 bacteria surveyed 62% without cellulases 38% with cellulases 1 13% saprophyte only 6% both 11% cellulose biosynthesisers only 8% others with unknown function M. tuberculosis organisms are among this 8% of bacteria with unknown function Mba Medie, F. et al: Genome analyses highlight the biological roles of cellulases Under revision in Nature Review Microbiology 11